Utilization and Cost Implications of Hematopoietic Progenitor Cells Stored for a Future Salvage Autologous Transplantation or Stem Cell Boost in Myeloma Patients-Reference-Cited by-同舟云学术

Utilization and Cost Implications of Hematopoietic Progenitor Cells Stored for a Future Salvage Autologous Transplantation or Stem Cell Boost in Myeloma Patients

Published:2020-11 Issue:11 Volume:26 Page:2011-2017
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Chhabra Saurabh,Thapa Bicky,Szabo Aniko,Konings Steve,D'Souza Anita,Dhakal Binod,Jerkins James H.,Pasquini Marcelo C.,Johnson Bryon D.,Hari Parameswaran N.,Hamadani Mehdi

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference36 articles.

1. Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma;Costa;Biol Blood Marrow Transplant,2013

2. Autologous transplantation for newly diagnosed multiple myeloma in the era of novel agent induction: a systematic review and meta-analysis;Dhakal;JAMA Oncol,2018

3. Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma;Attal;N Engl J Med,2017

4. Autologous transplantation and maintenance therapy in multiple myeloma;Palumbo;N Engl J Med,2014

5. High expression of endoplasmic reticulum chaperone grp94 is a novel molecular hallmark of malignant plasma cells in multiple myeloma;Chhabra;J Hematol Oncol,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying Candidates for Effective Utilization of Stored Autologous PBSCs in Salvage Transplantation for Multiple Myeloma: Who Benefits Most?;Hematology Reports;2024-07-12

2. Immune effector cell-associated haematotoxicity after CAR T-cell therapy: from mechanism to management;The Lancet Haematology;2024-06

3. Optimal approach to stem cell mobilization in transplant-eligible multiple myeloma patients;Journal of Cancer Metastasis and Treatment;2024-05-27

4. Optimizing autologous stem cell collections for patients with multiple myeloma receiving G‐CSF and Plerixafor: A single center project;Journal of Clinical Apheresis;2024-05-27

5. Outcomes of Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma Receiving Salvage Cytotoxic Therapy with Supportive Stem Cell Boost;Current Stem Cell Research & Therapy;2024-04-03